Low Eosinophils (Eosinopenia): Causes and Clinical Significance
Eosinopenia (eosinophil count ≤30-50/µL or <0.05 × 10⁹/L) most commonly results from acute bacterial infections, severe systemic inflammation, or corticosteroid administration, and serves as a marker of disease severity and poor prognosis in critically ill patients.
Primary Causes of Eosinopenia
Acute Infections and Inflammation
The most frequent cause of low eosinophils is acute bacterial infection or severe systemic inflammation 1. During acute inflammatory processes, eosinophils rapidly:
- Accumulate at inflammatory sites (peripheral sequestration)
- Experience inhibited egress from bone marrow
- Undergo suppressed eosinopoiesis with prolonged inflammation
This response occurs regardless of pathogen type—bacterial (pneumococcal, E. coli), viral (Coxsackie), or sterile inflammation (turpentine-induced) 1.
Severe Community-Acquired Pneumonia
Eosinopenia ≤30/µL predicts respiratory failure and mortality in hospitalized pneumonia patients 2, 3:
- Mechanical ventilation rates: 15.5% vs 7.3% in non-eosinopenic patients (RR 2.12)
- ICU admission rates: 23.1% vs 10.9% (RR 2.11)
- 30-day mortality independently increased (HR 1.95)
- Longer hospital stays among survivors
This threshold remains predictive regardless of corticosteroid treatment 2.
Sepsis and Critical Illness
Persistently low eosinophil counts associate with adverse outcomes in sepsis, though the mechanistic contribution remains incompletely understood 4. Eosinopenia reflects the severity of systemic inflammatory response.
Secondary Causes
Corticosteroid Administration
Glucocorticoids cause rapid eosinopenia through:
- Redistribution from circulation to tissues
- Suppression of eosinophil production
- Enhanced apoptosis
This is one of the most common iatrogenic causes in clinical practice.
HIV Infection
HIV can present with eosinophilia or eosinopenia 5, 6. When evaluating travelers or migrants with abnormal eosinophil counts, HIV testing is recommended as part of the differential workup 5.
Autoimmune Conditions
In chronic spontaneous urticaria, eosinopenia (present in 10% of patients) associates with 7:
- Type IIb autoimmunity (positive autologous serum skin test)
- High disease activity
- Poor response to antihistamines (OR 4.8) and omalizumab
- Low total IgE and elevated C-reactive protein
- When combined with basopenia: OR 9.5 for treatment nonresponse
Clinical Approach to Eosinopenia
Immediate Assessment
- Medication review: Check for recent corticosteroid use (systemic or high-dose inhaled)
- Infection screening: Look for signs of acute bacterial infection, pneumonia, or sepsis
- Severity markers: Assess for systemic inflammatory response (fever, tachycardia, hypotension, elevated CRP)
Risk Stratification
In hospitalized patients with pneumonia or sepsis, eosinophil count ≤30/µL mandates:
- Closer monitoring for respiratory deterioration
- Lower threshold for ICU-level care
- Anticipation of longer hospital course
- Recognition as independent mortality predictor
Differential Considerations
Eosinopenia is not typically caused by:
- Helminth infections (these cause eosinophilia) 5, 6
- Allergic conditions (these cause eosinophilia)
- Eosinophilic esophagitis (requires ≥15 eosinophils/hpf for diagnosis) 8, 9
Key Clinical Pitfalls
Do not dismiss eosinopenia as clinically insignificant—it is a simple, inexpensive biomarker that:
- Predicts clinical deterioration in acute infections
- Identifies high-risk patients requiring escalation of care
- Reflects severity of systemic inflammation
- May indicate treatment-resistant autoimmune disease
Avoid attributing eosinopenia solely to corticosteroids without excluding acute infection, as both may coexist and the prognostic value persists independent of steroid use 2.
The combination of eosinopenia with basopenia creates an even stronger predictor of poor outcomes in inflammatory conditions 7.